Alpha 2.0
Login Register
» Articles » PMID: 32931327

Developing Guidelines Before, During, and After the COVID-19 Pandemic

Overview
Journal Ann Intern Med
Specialty General Medicine
Date 2020 Sep 15
PMID 32931327
Citations 10
Authors
Zachary Munn
Sara Twaddle
Duncan Service
Elaine Harrow
Patrick Mbah Okwen
Holger Schunemann
Per Olav Vandvik
Affiliations
Soon will be listed here.
Citing Articles

Addressing evidence needs during health crises in the province of Quebec (Canada): a proposed action plan for rapid evidence synthesis.

Hong Q, McSween-Cadieux E, Guillette M, Manceau L, Li J, Granikov V BMC Health Serv Res. 2025; 25(1):61.

PMID: 39799371 PMC: 11725205. DOI: 10.1186/s12913-025-12204-y.

Addressing infodemic for pandemic preparedness in the digital age: a focus on Middle Africa.

Penka M, Tangang A, Alang Wung E, Tata Kelese M, Okwen P Front Public Health. 2024; 12:1275702.

PMID: 39421813 PMC: 11484489. DOI: 10.3389/fpubh.2024.1275702.

Key Learnings from the Development and Early Use of Global Guidance on the Integration of COVID-19 Vaccination into Broader Health Systems.

Dadari I, Vilajeliu A, Berdaga V, Rozario S, Meyer P, Nic Lochlainn L Vaccines (Basel). 2024; 12(2).

PMID: 38400179 PMC: 10892213. DOI: 10.3390/vaccines12020196.

Production and use of rapid responses during the COVID-19 pandemic in Quebec (Canada): perspectives from evidence synthesis producers and decision makers.

McSween-Cadieux E, Lane J, Hong Q, Houle A, Lauzier-Jobin F, Saint-Pierre Mousset E Health Res Policy Syst. 2024; 22(1):22.

PMID: 38351054 PMC: 10863098. DOI: 10.1186/s12961-024-01105-x.

Evaluation of the quality of COVID-19 guidance documents in anaesthesia using the Appraisal of Guidelines for Research and Evaluation II instrument.

OShaughnessy S, Dimagli A, Kachulis B, Rahouma M, Demetres M, Govea N Br J Anaesth. 2022; 129(6):851-860.

PMID: 36273932 PMC: 9485431. DOI: 10.1016/j.bja.2022.09.008.

References
1.
Agarwal A, Hunt B, Stegemann M, Rochwerg B, Lamontagne F, Ac Siemieniuk R . A living WHO guideline on drugs for covid-19. BMJ. 2020; 370:m3379. DOI: 10.1136/bmj.m3379. View
2.
Dagens A, Sigfrid L, Cai E, Lipworth S, Cheng V, Harris E . Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review. BMJ. 2020; 369:m1936. PMC: 7249097. DOI: 10.1136/bmj.m1936. View
3.
Page M, Welch V, Haddaway N, Karunananthan S, Maxwell L, Tugwell P . "One more time": why replicating some syntheses of evidence relevant to COVID-19 makes sense. J Clin Epidemiol. 2020; 125:179-182. PMC: 7247512. DOI: 10.1016/j.jclinepi.2020.05.024. View
4.
Morgan R, Florez I, Falavigna M, Kowalski S, Akl E, Thayer K . Development of rapid guidelines: 3. GIN-McMaster Guideline Development Checklist extension for rapid recommendations. Health Res Policy Syst. 2018; 16(1):63. PMC: 6043953. DOI: 10.1186/s12961-018-0330-0. View
5.
Vandvik P, Brandt L . Future of Evidence Ecosystem Series: Evidence ecosystems and learning health systems: why bother?. J Clin Epidemiol. 2020; 123:166-170. DOI: 10.1016/j.jclinepi.2020.02.008. View